D, W., K, W., A, T., K, G., C, C., K, T., . . . E, B. (2017). From the Children's Oncology Group: Evidence-Based Recommendations for PEG-Asparaginase Nurse Monitoring, Hypersensitivity Reaction Management, and Patient/Family Education. Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses, 34(6), 387. https://doi.org/10.1177/1043454217713455
Chicago Style (17th ed.) CitationD, Woods, Winchester K, Towerman A, Gettinger K, Carey C, Timmermann K, Langley R, and Browne E. "From the Children's Oncology Group: Evidence-Based Recommendations for PEG-Asparaginase Nurse Monitoring, Hypersensitivity Reaction Management, and Patient/Family Education." Journal of Pediatric Oncology Nursing : Official Journal of the Association of Pediatric Oncology Nurses 34, no. 6 (2017): 387. https://doi.org/10.1177/1043454217713455.
MLA (9th ed.) CitationD, Woods, et al. "From the Children's Oncology Group: Evidence-Based Recommendations for PEG-Asparaginase Nurse Monitoring, Hypersensitivity Reaction Management, and Patient/Family Education." Journal of Pediatric Oncology Nursing : Official Journal of the Association of Pediatric Oncology Nurses, vol. 34, no. 6, 2017, p. 387, https://doi.org/10.1177/1043454217713455.